UnitedHealth Group (NYSE: UNH ) delivered a mixed Q2 FY2025 earnings report. Although revenue slightly topped the consensus, its EPS came in significantly below estimates. This wasn't all that surprising, especially after management had foretold an incoming "disaster" by pulling out Analyst's Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresse ...